REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First

Similar documents
Nutritional Interventions in Primary Mitochondrial Disorders

MITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital

Presentation and investigation of mitochondrial disease in children

An Introduction to mitochondrial disease.

Referring Physician Information Name: (Last, First, Middle):

Mitochondrial Diseases

The Organism as a system

Neurological Mitochondrial Cytopathies

MITOCHONDRIAL DISORDERS IN NEUROLOGY

In the past 13 years, a new chapter of human genetics, mitochondrial genetics, has opened

The mitochondrion and its disorders

FORM ID. Patient's Personal Details. SECTION A : Medical Record of the Patient. Name. Policy Number. NRIC/Old IC/Passport/Birth Cert/Others

MNGenome Sequencing Test Request Form

Diagnosis and Therapy in Neuromuscular Disorders: Diagnosis and New Treatments in Mitochondrial Diseases

PHYSICIAN S REPORT SPECIAL NEEDS Patient s Name: Date of Birth:

3855 Burton Street SE Suite A, Grand Rapids, MI Phone Fax Patient Information. Address: City: State: Zip:

Predominant Cerebellar Volume Loss as a Neuroradiologic Feature of Pediatric Respiratory Chain Defects

Guiding Eyes for the Blind 611 Granite Springs Road, Yorktown Heights, New York PHONE FAX

BASED ON A PAPER READ TO SEC77ON OF PAEDIATRICS, 25 JANUARY Table 1. Disease

MYOCLONIC EPILEPSY WITH RAGGED RED FIBERS (MERRF) By- Promie Faruque

Patient Information. Client/Responsible Party Signature: Date: Legal Representation (If applicable): Name: Signature:

Child s Information (Please print) Name Birth Date Age Home Address City State Zip Code

Evergreen Speech & Hearing Clinic, Inc. Transforming Lives Through Improved Communication Since 1979

Movement Disorders Requisition Form

Committee to Review Adverse Effects of Vaccines An Institute of Medicine Workshop on the Safety of Vaccines. Mitochondrial Disorders

THIAMINE TRANSPORTER TYPE 2 DEFICIENCY

Mitochondrial Cytopathies

Biochemistry of cellular organelles

Patient Name: First MI Last Preferred Name. DOB: Sex: MALE FEMALE SSN: Address: City: State: Zip Code:

Patient Medical Information. Last. Sex: M / F Age: Date of Birth: Home Address: City: State: Zip Code: Business Address: City: State: Zip Code:

MNG Exome Sequencing Test Request Form

PHYSICIAN S REPORT Patient s Name: Date of Birth:

Robert Barski. Biochemical Genetics St James s University Hospital, Leeds. MetBioNet IEM Introductory Training

This page is for information. Do not submit.

Medical Prescription to Train a Service Dog

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism

Lake Psychological Services, LLC

PHYSICIAN S STATEMENT OF EXAMINATION

TEXAS VASCULAR ASSOCIATES, P.A. PATIENT CLINICAL INTAKE FORM

Intellectual Disability Exome Panel Requisition Form

Patient Name (First, Middle, Last) Height Weight. Ethnicity Race Language. Address. City State Zip. Home Phone Cell Phone. Work Phone Other Phone

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

SCAD and GA-II: Truths and Confusions

AUTISM SCIENCE DIGEST: THE JOURNAL OF AUTISMONE ISSUE 01 APRIL 2011 REPRINTED WITH PERMISSION

SURGICAL BREAST PRACTICE NEW PATIENT QUESTIONNAIRE

YES. If yes, indicate what types of tumors/polyps and age of onset:

We know these take time to gather, so please plan ahead!

Date: New Patient Form First Visit Date:

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

NC Neuropsychiatry, PA HEALTH QUESTIONNAIRE

Patient Last Name First Name Middle Name. Home Address City State Zip. Date of Birth Age Social Security # - - Cell Phone Home Phone Work Phone

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other:

Moms Help Organization Helping Moms to be the best Moms they can be! West Sample Road, #24 Coral Springs, FL

Dear Incoming Student:

Preferred Name: First Name: Last Name: Middle Initial: Mailing Address: City: State: Zip: Alternate number: address:

Revelation Chiropractic Health Profile

MISSOURI SPINE INSTITUTE John D. Spears, D.O.

Our office is located at 2030 Drew Street, Clearwater FL, We are on Drew Street, in between N.E Old Coachman Road and Hercules Avenue.

Last Name First Name MI SS# DOB. Address. City State Zip. Best Phone# (home/ work/ cell) Alternate # (home/ work/ cell)

Newcastle Mitochondrial Disease Guidelines

Over. Signature of Patient/Parent/Guardian: Date: / / Date: / / Patient s Name: For ADULT Patients : Employer: Address: Occupation:

Following this letter are health forms for parents or legal guardians to complete and sign. Please note that:

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

New Patient Paperwork

Appendix B: Provincial Case Definitions for Reportable Diseases

Mitochondrial Disease

Denise L. Newman, Ph.D.

RE-REGISTRATION FORM

Comfort Foot Care HIPPA COMPLIANCE FORM. Home Phone Cell phone Mail SMS

Patient Information. Patient Name: DOB: Last First M.I. Home Address: City: State: Zip: Home Phn: Cell Phn: Alt. Phn: SSN:

Evergreen Speech & Hearing Clinic, Inc. Transforming Lives Through Improved Communication Since 1979

What we need from you:

NEW PATIENT REGISTRATION PLEASE COMPLETE ALL ITEMS ON EACH PAGE. Name (Last, First, M.I.) Address. City State Zip Code. Phone ( ) Work ( ) Cell ( )

Childhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings, mtdna mutations and outcome in six children

Case History. CPC: Recurrent ptosis and visual disturbances. Case History. Case History

New Patient Intake Form

PHYSICIAN PACKET Big Branch Rd. Middleburg, FL (904)

Patient Name: Date of Birth: Patient Name: DOB: Patient Guardian/Representative: How old are you. Handed: Right Left Ambidextrous Male

Mitrochondrial Disease

Shallotte Vision Care J. Mark Saunders, OD PA 4637 Main Street Shallotte NC Patient Demographic Information

Evaluation of the Hypotonic Infant and Child

Cardiomyopathy in children with mitochondrial disease

Feil & Oppenheimer Psychological Services

Name Age Birthday / / Sex Last First MI. Home Address Street Apt City State Zip Code Home phone: ( ) Cell phone: ( ) Name of parent(s) or guardian:

Clinical mitochondrial genetics

Dear Incoming Student:

New Patient Documentation. Name: (Last) (First) (Middle) Address: (Street) (Apt#) (City) (State) (Zip) Home Phone: ( ) Cell: ( ) Work: ( )

PATIENT BASIC INFORMATION FORM (To be filled out by patient)

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still

Preferred phone: Best time to call you: Morning Afternoon Evening

Case Report Motor Neuron Syndrome as a New Phenotypic Manifestation of Mutation 9185T>C in Gene MTATP6

Type of Patient and/or payment method (circle one)

Patient Name: 1831 N. Belcher RD Suite C3 Clearwater, FL Phone: Fax: Authorization to Release Protected Information Da

Neurology. Access Center 24/7 access for referring physicians (866) 353-KIDS (5437)

SPOKANE COMMUNITY COLLEGE HEALTH SCIENCE PROGRAMS 1810 N GREENE STREET, MS 2090 SPOKANE WA PHYSICAL EXAMINATION (Student completes this side)

PATIENT INFORMATION. Soc. Sec. #: First Initial Last. Name Relationship Phone Number. Employer. Occupation

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance

What we need from you:

Evergreen Speech & Hearing Clinic, Inc. Transforming Lives Through Improved Communication Since 1979

Transcription:

#: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED Name: Referring Physician Information Patient Information Name: Last First Last First City: State: Zip: City: State: Zip Phone: Fax: Phone: SS #: Sex: Date of Birth: Age: Clinical Information Tissue submitted: Blood Muscle Other: Billing Information Charges will be billed to the submitting institution/physician Institution: Department: Date Specimen Taken: Date Specimen Sent: Phone: Blood & Fluid Precautions? Yes No Presenting Complaint: PATIENT OR INSURED/RESPONSIBLE ADULT AUTHORIZATION: Signature: Date:

TESTS REQUESTED (please check appropriate boxes) I. PCR/RFLP ANALYSES TO DETECT MTDNA POINT MUTATIONS - $225 PER MUTATION Clinical Phenotype Nucleotide Comment Test Requested MELAS/MERRF/NARP battery (6 most frequently observed mutations*) MELAS 3243* Frequent " 3256* " 3271* " 3291 " 5814 " 8356* MERRF overlap " 9957 MELAS battery (7 mutations) MERRF 8344* Frequent " 8356* MELAS overlap " 8363 " 3243* MELAS overlap MERRF battery (4 mutations) NARP/Leigh syndrome (MILS) 8851 " 8993* T G; T C " 9176 NARP/MILS battery (3 mutations) PEO 3243 Frequent " 3256 " # 5703 PEO battery (3 mutations) LHON 3460 " 11778 Frequent " 14484 LHON battery (3 primary mutations) Myopathy 3250 " 3260 " # 3302 " # 15990 Myopathy battery (4 mutations) Cardiomyopathy 3243 " 3260 " 3303 " 4269 " 4300 " 8363 " 9997 Cardiomyopathy battery (7 mutations) # These mutations are difficult to detect in blood; a muscle biopsy is preferred

POINT MUTATIONS ASSOCIATED WITH OTHER DISORDERS Aminoglycoside-induced deafness 1555 Diabetes (often with deafness) 3243 Myopathy, ptosis, psychiatric problems 3251 Retinopathy, diabetes, dementia 3252 Seizures, PEO, diabetes, deafness 3256 Cardiomyopathy, deafness, epilepsy 4269 Chorea, dementia, ataxia, deafness 5549 Sensorineural deafness 7445 Sensorineural deafness, ataxia, myoclonus 7271 GE reflux, ADD, asthma 10044 LHON, dystonia 14459 Diabetes, myopathy 14709 Infantile respiratory deficiency 15923 II. SOUTHERN BLOT TO DETECT MTDNA REARRANGEMENTS $ 500 Clinical Phenotype: Sporadic Kearns-Sayre syndrome; Sporadic PEO; Familial PEO III. QUANTITATIVE PCR TO DETECT MTDNA DEPLETION $ 500 IV. GENE SEQUENCING (PER GENE) $ 500 VI. MITOCHONDRIAL ENZYME ANALYSIS $ 550 Panel of 6 enzymes: Cytochrome c oxidase; Succinate cytochrome c reductase; NADH-cytochrome c reductase; NADH-dehydrogenase; Citrate synthase; Succinate dehydrogenase VII. THYMIDINE PHOSPHORYLASE ASSAY $ 400 MNGIE syndrome (Mitochondrial neurogastrointestinal encephalomyopathy) VIII. COENZYME Q10 Blood $ 100 Muscle $ 200 Rather than specifying any specific tests, check here to authorize any and all testing to be performed by Columbia-Presbyterian Medical Center, based on the information provided. Physician's signature Date

MITOCHONDRIAL DISEASE PATIENT DATA ENTRY FORM Patient Name: Date: CLINICAL INFORMATION: Clinical diagnosis: Age of onset: Clinical features (circle appropriate responses; Y = yes; N = no; NA = information not available) Symptoms Signs 1st symptom: Floppy baby Y N NA Perinatal insult Y N NA Asthenia Y N NA Developmental delay Y N NA Short stature Y N NA Retarded in school Y N NA Hirsute Y N NA Exercise intolerance Y N NA Congestive heart failure Y N NA Nausea/vomiting Y N NA Resp. insufficiency Y N NA Gastrointest. pseudoobstruction Y N NA Diabetes mellitus Y N NA Headache Y N NA Hypothyroidism Y N NA Migraine headache Y N NA Hypoparathyroidism Y N NA Stroke Y N NA Optic atrophy Y N NA Episodic coma Y N NA Ophthalmoplegia Y N NA Dementia Y N NA Ptosis Y N NA Seizures Y N NA Retinopathy Y N NA Myoclonus Y N NA Cerebral blindness Y N NA Cerebellar signs Y N NA Hearing loss Y N NA Proximal limb weakness Y N NA Neuropathy Y N NA Other: Other: State neuropathy type: LABORATORY STUDIES: IMAGING STUDIES: Elevated lactate Y N NA Angiogram Normal Abnormal NA Elevated pyruvate Y N NA MRI Normal Abnormal NA Elevated CSF protein Y N NA SPECT Normal Abnormal NA ECG - Heart Block Y N NA CBF Normal Abnormal NA ECG - Pre-excitation Y N NA CT Normal Abnormal NA EMG/NCS - Myopathic Y N NA BG calcification: Y N NA EMG/NCS - Neurogenic Y N NA Axonal Demyelinating Mixed NA Heart block Pre-excitation NA Other: Other: Positive family history: Y N NA Died: Y N If yes, please explain: Autopsy: Y N IMPORTANT: TO ASSIST IN DETERMINING THE MOST RELEVANT TESTS, PLEASE ATTACH COPIES OF MUSCLE HISTOLOGY AND BIOCHEMISTRY REPORTS, IF AVAILABLE

DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS AND SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax #: 212-305-3986 CONSENT FOR MITOCHONDRIAL DISEASE TESTING I, hereby agree to have biochemical and DNA-based testing performed in order to detect mitochondrial disease. This testing will be performed on muscle biopsy tissue previously obtained or on blood drawn for this purpose. If blood will be drawn, I understand that: 1. Approximately 10ml (about 1 tablespoon) of my blood will be drawn from a vein. I understand that this procedure will cause a sudden pain which will quickly disappear and may be followed by a black and blue mark. 2. In the laboratory, DNA, the material that carries the genetic information, will be extracted from the blood that is drawn. 3. Depending on a patient s particular condition, specific studies will be performed in the laboratory trying to identify a specific alteration in the DNA. These tests are >99% accurate, but rare variation in the DNA of individuals may sometimes cause uncertainty in interpretation of the results. 4. A negative result will exclude the presence of a particular mutation (or mutations) that were tested for in the tissue that was analyzed. However, it does not exclude the possibility that you carry other DNA mutations or that a particular mutation is present in tissues other than those that were tested. 5. In muscle biopsy tissue, the activities of 6 mitochondrial enzymes will be tested. I understand that the condition of the muscle specimen must be adequate for enzyme analysis and that sometimes there may be uncertainty in interpretation of the results. 6. The test results will be reported to the physician who submits the sample and I can then discuss these with them and may also request genetic counseling. My signature below constitutes acknowledgment that the proposed testing has been satisfactorily explained to me and that I hereby give my authorization and consent for this testing. Signature (Participant or Legal Guardian) Date